Space Industry and Business News  
EPIDEMICS
Brazil's Lula visits anti-retroviral plant in Mozambique

by Staff Writers
Maputo (AFP) Nov 10, 2010
Brazilian President Luiz Inacio Lula da Silva on Wednesday visited what is set to become Africa's first public factory for anti-HIV drugs, closing his last official visit to Africa with a focus on the fight against AIDS.

Lula, who hands over the reins to protege Dilma Rousseff on January 1, called the new anti-retroviral (ARV) drug factory in Mozambique a "revolution" for Africa's efforts to control the disease.

"The fact that we are building the African continent's first factory to produce anti-AIDS drugs can be seen as a revolution," Lula said at the plant on the outskirts of the Mozambican capital Maputo, a stop en route to this week's G20 summit in Seoul.

The 25-million-dollar (18.1-million-euro) factory is being built with the help of 21 million dollars in aid from Brazil and is expected to begin packaging Brazilian-made pills by the end of 2011, producing its own pills by the end of 2012.

Lula, who proposed the idea on a state visit to Mozambique during his first year in office in 2003, toured the site of the new facility and inspected its first piece of equipment, a packaging machine donated by Brazil.

He said he hopes to return to inaugurate the factory when it is complete.

"We have a new president who's going to take over in Brazil on January 1, so I want to be here as a guest together with (Mozambican) President (Armando) Guebuza when Mozambique's anti-retroviral factory produces its first pill."

Mozambique has more than 2.5 million people living with HIV -- nearly 12 percent of the population -- but just 210,000 take ARVs, according to the Mozambican health ministry.

The country depends on foreign aid to finance 80 percent of its HIV medication.

The factory aims to help Mozambique increase the availability and affordability of ARVs, following in Brazil's footsteps in the fight against AIDS.

Brazil famously offers free ARV treatment to every HIV-positive citizen, a programme that sparked controversy when it was announced in 1996 because of concerns about drug resistance and violation of pharmaceutical copyrights.

But it has since been praised as a model for the developing world. The World Bank estimates the free medicine saved more than half a million lives.

While several private laboratories in Africa have ventured into small-scale ARV production, the Mozambican factory will be the first public facility on the continent to produce the drugs.

"We have been confronting one of the worst public health problems using only preventive methods," Health Minister Alexandre Manguele told AFP.

Manguele said he estimates that only half the Mozambicans who need ARV treatment are receiving it.

"With the launch of the factory, we'll produce the medicine we need here. We'll be able to extend people's lives and turn this deadly disease into a chronic illness that we're able to treat," he said.

The factory aims to produce five different types of ARVs for a total output of 226 million pills a year. Officials said it will also produce 145 million pills of other types, including antibiotics.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
Haiti capital battles arrival of cholera
Port-Au-Prince (AFP) Nov 10, 2010
Aid groups fought Wednesday to halt the spread of cholera in Haiti's teeming capital, where makeshift camps crammed with earthquake survivors are ripe ground for the epidemic to take hold. The outbreak erupted in the Artibonite River valley in central Haiti in mid-October and initially seemed to have been contained, but the toll from the chronic diarrheal disease has since soared to 643 dead ... read more







EPIDEMICS
Tetris Flashback Reduction Effect Not Common To All Game

NIST Pings Key Material In Sonar, Closes Gap On Structural Mystery

Android now second biggest smartphone platform: Gartner

Pirate Chinese versions of Japan e-books sold online:reports

EPIDEMICS
ManTech Awarded US Army Contract To Provide ECCS In Afghanistan

Hughes Undergoing Wideband Global SATCOM Certification

ORBIT To Supply Tri-Band Telemetry Tracking Systems To Patuxent River USNAWC

Raytheon To Provide Improved Track Correlation And Fusion Capability

EPIDEMICS
Fifth Ariane 5 Ready To Receive Its Satellite Payloads

Vega P80 First Stage Is Rolled Out To The Spaceport's Vega Launch Facility

Pratt and Whitney Rocketdyne Engine Helps Boost 350th Launch Of A Delta Vehicle

India Plans Two Rocket Launches Next Month

EPIDEMICS
Lockheed Martin Delivers Key GPS III Test Hardware Ahead of Schedule

Few Americans using location-based services: Pew study

GPS maker Garmin hanging up on smartphones

Savi Challenges You To Imagine The Best Wireless Applications

EPIDEMICS
Britain signs jet engine deal with China as PM visits

Flights resume to Indonesia after volcano chaos

Argentina, Brazil to build cargo plane

BOC Aviation orders 30 Airbus A320

EPIDEMICS
Microsoft sues Motorola over 'excessive' royalty demands

Motorola fires back against Microsoft in patent dispute

Intel opens biggest ever chip plant in Vietnam

Intel to open billion-dollar chip plant in Vietnam

EPIDEMICS
Go For Getz And A South Pole Flyover

FCC investigating Google 'Street View' data harvest

NASA Study Quantifies Role Of Melt In Loss Of Old Arctic Sea Ice

Nicaragua, Costa Rica tense over map 'war'

EPIDEMICS
U.S. Army seeking quick water test

BPA eliminated through urination: WHO

One by one, Laos's cluster bombs legacy goes up in smoke

China to rein in dioxin emissions to help air quality


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement